How can healthcare and life sciences organizations control GenAI recordkeeping risks?
With the use of generative AI tools like ChatGPT increasing within healthcare and life sciences organizations, how can businesses balance compliance and modernization while tapping into the benefit AI can offer?
FINTRAC fines five firms over C$350,000 for AML failures
Canada's anti-money laundering (AML) regulator FINTRAC has issued fines totalling over C$350,000 to five firms for multiple breaches of the Proceeds of Crime and Terrorist Financing Act.
Has the SEC shifted focus in its 2026 Examination Priorities?
The SEC’s Examination Priorities for 2026 include focus areas that align with emerging risks, as well as an emphasis on ensuring compliance programs are effective – though, notably, it make no mention of digital assets.
Record C$176 million FINTRAC fine for AML failings
Canada’s anti-money laundering watchdog fined Xelox Enterprises Ltd C$176 million for violating anti-money laundering regulations under the Proceeds of Crime and Terrorist Financing Act.
Closing compliance gaps: How can enterprise firms unify surveillance across business lines?
Ensuring complete compliance across business lines can be tricky. Learn how firms can satisfy regulators while keeping data secure and operations seamless.
Building AI agents for tomorrow: A governance-first approach
Global Relay Group Product Manager, Chris Lau, tells us how the implementation of AI agents should lead with a governance-first approach, and sets out 12 considerations to build AI agents with future regulation in mind.
FINTRAC issues a C$600,000 fine for transaction monitoring failures
Canada’s anti-money laundering watchdog fined the First Nations Bank of Canada C$600,000 for violating multiple regulations, including a failure to regularly monitor business relationships for suspicious transactions.
Regulatory Wrap episode 72: FCA’s call to action on financial crime
In Regulatory Wrap for the week to October 10, Jay Hampshire summarizes the FCA’s recent speech encouraging collaboration to fight financial crime.
Regulatory Wrap Episode 71: FDA takes aim at pharma companies’ social media activity
In Regulatory Wrap for the week to October 3, Ryan Thaxton explores the growing spotlight on pharma companies’ social media activity.
Regulatory Wrap episode 70: What the CFTC’s “enforcement sprint” means for compliance
In Regulatory Wrap for the week to September 12, Kathryn Fallah reviews recent enforcement action from the CFTC against 10 firms for technical compliance failures.